ATLANTA, March 20, 2018 /PRNewswire/ -- CryoLife,
Inc. (NYSE: CRY), a leading cardiac and vascular surgery
company focused on aortic disease, announced today that it will
participate in the upcoming 17th Annual Needham
Healthcare Conference on Tuesday, March 27,
2018 at the Westin Grand Central in New York.
A live webcast of the Company's presentation is scheduled to
begin at 3:30 p.m. ET and will
feature an overview of the company by Pat
Mackin, Chairman, President and Chief Executive
Officer.
The live webcast can be accessed through CryoLife's website,
www.cryolife.com, on the Investor Relations page. An archived
copy of the webcast will be available for 90 days on the same
website.
About CryoLife
Headquartered in suburban Atlanta,
Georgia, CryoLife is a leader in the manufacturing,
processing, and distribution of medical devices and implantable
tissues used in cardiac and vascular surgical procedures focused on
aortic repair. CryoLife markets and sells products in more
than 90 countries worldwide. For additional information about
CryoLife, visit our website, www.cryolife.com.
Contacts:
|
|
|
|
CryoLife
|
The Ruth
Group
|
D. Ashley
Lee
|
Tram Bui / Emma
Poalillo
|
Executive Vice
President, Chief Financial Officer and
|
646-536-7035 /
7024
|
Chief Operating
Officer
|
tbui@theruthgroup.com
|
Phone:
770-419-3355
|
epoalillo@theruthgroup.com
|
|
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/cryolife-to-present-at-17th-annual-needham-healthcare-conference-300616346.html
SOURCE CryoLife, Inc.